首页> 外文期刊>Molecular biology of the cell >Phospholipase A2 Antagonists Inhibit Nocodazole-induced Golgi Ministack Formation: Evidence of an ER Intermediate and Constitutive Cycling
【24h】

Phospholipase A2 Antagonists Inhibit Nocodazole-induced Golgi Ministack Formation: Evidence of an ER Intermediate and Constitutive Cycling

机译:磷脂酶A2拮抗剂抑制诺考达唑诱导的高尔基体小堆栈形成:ER中间和组成性循环的证据。

获取原文
           

摘要

Evidence has been presented both for and against obligate retrograde movement of resident Golgi proteins through the endoplasmic reticulum (ER) during nocodazole-induced Golgi ministack formation. Here, we studied the nocodazole-induced formation of ministacks using phospholipase A2 (PLA2) antagonists, which have been shown previously to inhibit brefeldin A–stimulated Golgi-to-ER retrograde transport. Examination of clone 9 rat hepatocytes by immunofluorescence and immunoelectron microscopy revealed that a subset of PLA2 antagonists prevented nocodazole-induced ministack formation by inhibiting two different trafficking pathways for resident Golgi enzymes; at 25 μM, retrograde Golgi-to-ER transport was inhibited, whereas at 5 μM, Golgi-to-ER trafficking was permitted, but resident Golgi enzymes accumulated in the ER. Moreover, resident Golgi enzymes gradually redistributed from the juxtanuclear Golgi or Golgi ministacks to the ER in cells treated with these PLA2 antagonists alone. Not only was ER-to-Golgi transport of resident Golgi enzymes inhibited in cells treated with these PLA2 antagonists, but transport of the vesicular stomatitis virus G protein out of the ER was also prevented. These results support a model of obligate retrograde recycling of Golgi resident enzymes during nocodazole-induced ministack formation and provide additional evidence that resident Golgi enzymes slowly and constitutively cycle between the Golgi and ER.
机译:已有证据表明诺考达唑诱导的高尔基迷你堆栈形成过程中驻留高尔基蛋白通过内质网(ER)逆行专性迁移。在这里,我们使用磷脂酶A 2 (PLA 2 )拮抗剂研究了诺考达唑诱导的小细胞叠层的形成,该拮抗剂先前已显示出抑制布雷菲德菌素A刺激的高尔基体对高尔基体的抑制作用。 ER逆行运输。用免疫荧光和免疫电子显微镜检查了9个克隆的大鼠肝细胞,发现一部分PLA 2 拮抗剂通过抑制驻留的高尔基酶的两种不同的运输途径来阻止诺考达唑诱导的小堆栈形成。在25μM时,逆行的高尔基体到ER转运受到抑制,而在5μM时,允许高尔基体到ER的运输,但内含高尔基酶在ER中积累。此外,在单独用这些PLA 2 拮抗剂处理的细胞中,常驻高尔基酶逐渐从近核高尔基体或高尔基体小堆栈重新分布到ER中。在用这些PLA 2 拮抗剂处理的细胞中,不仅内源高尔基酶从ER向高尔基体的转运受到抑制,而且还阻止了水疱性口炎病毒G蛋白从ER内转运。这些结果支持了在诺考达唑诱导的小堆栈形成过程中高尔基驻留酶专性逆行回收的模型,并提供了其他证据,表明高尔基驻留酶在高尔基体和内质网之间缓慢而组成性循环。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号